CSL Behring Provides Update on Stimate Nasal Spray Availability

The following is an excerpt from an update from CSL Behring regarding the availability of Stimate Nasal Spray. Read the update in its entirety here.

Ferring Pharmaceuticals Inc. initiated a voluntary, consumer-level recall of all batches of Stimate® Nasal Spray (desmopressin acetate) 1.5 mg/mL, which is distributed and sold by CSL Behring LLC.  At this time, Ferring does not anticipate resupply before 2022.
HFA reminds you to please reach out to your physician with any medical concerns. You can also contact CSL Behring’s Medical Information Phone Line at 1-800-504-5434.
Please note that HFA  does not recommend, endorse or make any representation about the efficacy, appropriateness or suitability of any specific products, treatments or opinions. If you have any questions or concerns about your medical treatment, including your possible exposure to recalled product, please consult your physician. 
Read the update in its entirety here.